• Seeking Alpha

Maze Therapeutics to Present Additional Data Highlighting the Advancement of MZE829 and MZE782 Programs at ASN Kidney Week

Seeking Alpha / 1 hour ago 1 Views

Maze Therapeutics to Present Additional Data Highlighting the Advancement of MZE829 and MZE782 Programs at ASN Kidney Week
Read more
  • Source:
  • GlobeNewswire - News about Public Companies
Previous post
Microchip Technology Unveils Model Context Protocol (MCP) Server to Power AI-Driven Product Data Access
Next post
Baker Hughes Secures Additional Order for Rio Grande LNG Expansion

Comments

Just Posted

  • Novo Nordisk announces agreement with the U.S. Administration to bring GLP-1s to more Americans at a lower cost

    4 hours from now

  • Banco Comercial Português, S.A. informs on notice of transaction of securities

    4 hours from now

  • Banco Comercial Português, S.A. informa sobre notificação de transação de títulos

    4 hours from now

  • CREDIT AGRICOLE S.A. ANNOUNCES REDEMPTION OF ¥17,700,000,000 Japanese Yen Callable Senior Non-Preferred Bonds issued on December 7, 2022 (ISIN: JP525022CNC9)

    4 hours from now

  • CREDIT AGRICOLE S.A. ANNONCE LE REMBOURSEMENT DE SES Obligations senior non préférées remboursables émises le 7 décembre 2022 pour un montant nominal total de ¥17.700.000.000 JPY (ISIN: JP525022CNC9)

    4 hours from now

Tags

  • SA Transcripts
  • TOU:CA
  • Gold Mining Bull
  • TPZ
  • NG1:COM
  • CHK
  • TRMLF
  • fivn
  • CGIFF
  • CHE.UN:CA

Reviews

Categories

  • Seeking Alpha 1826

Categories

  • Seeking Alpha 1826

Pages

Tags

  • SA Transcripts
  • TOU:CA
  • Gold Mining Bull
  • TPZ
  • NG1:COM
  • CHK
  • TRMLF
  • fivn
  • CGIFF
  • CHE.UN:CA

Copyright News That Move � 2018. All Rights Reserved

  • Seeking Alpha
  • Trade Halts